LIMN

Liminatus Pharma, Inc. Class A Common Stock NASDAQ Listed May 1, 2025

Healthcare ·Biotechnology ·US · liminatuspharma.com

$0.11

Pre-mkt $0.13 +13.33%

Mkt Cap $3.1M

52w Low $0.10 0.2% of range 52w High $10.75

50d MA $0.17 200d MA $0.66

P/E (TTM) —

EV/EBITDA —

P/B —

Debt/Equity -0.1x

ROE 104.0%

P/FCF -0.3x

RSI (14) 33.90

ATR (14) $0.01

Beta 0.63

50d MA $0.17

200d MA $0.66

Avg Volume 18.3M

Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.

CIK (SEC)

1971387

Phone

213 273 5453

6 Centerpointe Drive · La Palma, CA 90623 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 31, 2026	AMC	—	-0.03	—	0.17	+0.1%	-0.5%	+2.3%	+6.6%	-1.1%	-0.3%	—
Nov 13, 2025	AMC	—	-0.07	—	1.07	-4.7%	+0.0%	-0.9%	+4.7%	+0.9%	-6.2%	—
Oct 3, 2025	AMC	—	-0.05	—	1.73	+1.7%	+0.0%	-8.7%	+1.3%	-4.4%	-7.8%	—

Institutional (13F) — Top 10 All ↗

#	Manager	Shares	Value	Chg	Period
1	Linden Advisors Lp	268,199	$11K	—	Dec 2025
2	D.e. Shaw & Co	83,353	$3K	—	Mar 2026
3	Blue Owl Capital Holdings Lp	50,000	$2K	—	Mar 2026
4	Periscope Capital Inc.	47,500	$2K	—	Mar 2026
5	Wolverine Asset Management Llc	39,373	$2K	Reduced	Mar 2026
6	Toronto Dominion Bank	35,100	$1K	—	Dec 2025
7	Jane Street Group, Llc	24,274	$850	Reduced	Dec 2025
8	Dupont Capital Management Corp	6,250	$306	—	Mar 2026
9	Ubs Group Ag	4,507	$180	Added	Mar 2026
10	Hgc Investment Management Inc.	1,250	$50	—	Mar 2026

Mutual Funds / ETFs (N-PORT) — Top 2 All ↗

#	Fund	Shares	Value	Period
1	Saba Capital Income & Opportunities Fund	27,683	$970	Jan 2026
2	Calamos Market Neutral Income Fund	6,250	$232	Jan 2026

Data updated apr 25, 2026 7:13pm · Source: financialmodelingprep.com